The introduction of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the weight loss community. This innovative dual GIP and GLP-1 agonist medication appears to deliver notable improvements in weight reduction compared to existing therapies. Preliminary patient t